Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

July’s top stories: NCI and COG’s paediatric precision cancer trial, AstraZeneca’s NSCLC trial results

NIH’s unit NCI and the COG initiated patient enrolment in a paediatric Phase II clinical trial to evaluate targeted cancer medicines, and AstraZeneca reported positive results from the FLAURA trial of Tagrisso to treat patients with locally advanced or metastatic NSCLC. Drugdevelopment-technology.com wraps up the key headlines from July.

Go Top